Salvage re-irradiation options in adult medulloblastoma: A case report and review of the literature

2Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Background/Aim: Medulloblastoma is a rare tumor of adult age, while it occurs more frequently in children. Given the rarity, there is a lack of evidence for the treatment of recurrent disease. Few data are available about salvage reirradiation collecting very heterogeneous series. Case Report: A 51-year-old male presented with headache, nausea, double vision, and gait disorders. A contrast-enhanced brain-MRI showed the presence of multifocal medulloblastoma. After surgery, adjuvant craniospinal radiotherapy was performed, chemotherapy was stopped due to toxicity. After 27 months, a new MRI and a Methionine-PET revealed a late pontocerebellar relapse; multidisciplinary board decided for a SBRT treatment. The second course of RT was well tolerated and 14 months later, the patient is alive in good general conditions, with no evidence of disease. Conclusion: Our experience supports the use of salvage stereotactic radiotherapy as a safe and effective treatment option.

Cite

CITATION STYLE

APA

Cuccia, F., Mortellaro, G., Ognibene, L., Craparo, G., Casto, A. L. O., & Ferrera, G. (2020). Salvage re-irradiation options in adult medulloblastoma: A case report and review of the literature. In Vivo, 34(3), 1283–1288. https://doi.org/10.21873/invivo.11903

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free